This Friday through a press conference, the Ministry of Health and Social Protection informed that the country will arrive vaccines against Monkeypox, known as ‘mpox’, in the framework of cooperation between Japan and Colombia.
As confirmed by the Minister of Health and Social Protection, Carolina Corcho, who stated that a cooperation agreement between the Ministry of Health and the Ministry of Health, Labor and Welfare of Japan. The document contemplates the donation of “thousands of doses of vaccines we would need against monkeypox”. According to the Ministry, 25,000 organics will be donated.
The Japanese ambassador in Colombia, Takasugi Masahiro, for his part, highlighted his satisfaction in informing the bilateral decision after the request of the government of Colombia to his country.
At the moment, the date of arrival of the vaccine in the country is not known, but Minister Corcho confirmed that these vaccines will not be delivered to Health Promotion Bodies (EPS) and groups at risk will be targeted.
It must be taken into account that this vaccine is a organic approved by the World Health Organization (WHO), based on a Japanese vaccine used in the 1970s, has shown efficacy in treating the monkeypox epidemic. As confirmed by the Japanese ambassador, “contribute to the containment of monkeypox and that this Japanese vaccine is recognized worldwide”.
For his part, Minister Corcho stressed that the acquisition process He was accompanied by infectious disease specialist Carlos Álvarez, who currently works with the WHO on covid-19 issues as a representative. Likewise by Professor Hernando Gaitán, director of the Clinical Research Institute of the National University of Colombia.
The head of the portfolio similarly mentioned that the academics have been collaborating with experts from the Ministry of Health and Japan’s health portfolio to carry out the relevant protocols related to donation and inoculation in the country. This group also had the support of Invima to be able to carry out the respective legalization procedures for the entry of the vaccine into the country.”, highlighted Cork.
It is worth mentioning that, currently in Colombia, with data revealed by the National Institute of Health (INS) reported that up to this Monday, November 28, there have been 3,852 confirmed cases of monkeypox in the country. Of these, 3,701 people recovered, most of whom were from the capital (1,885) and Antioquia (1,077).
The institution could have greater difficulties in monitoring the infections because 81.1% correspond to an unknown source and, according to the data, 11% of the affected population has had contact with those whose origin is unknown.
As regards the cases imported from abroad, 1.7% of those affected correspond to this cause and 2.4% were infected by some contact with that sample group. Similarly, the INS is studying 3.8% of the confirmed infected, or 146 people.
The regions with the highest number of infections are Bogotá (1,932), Antioquia (1,114) and Cali (310).
The other cases occurred in the following departments: Cundinamarca (87), Santander (80), Tolima (49), Risaralda (47), Barranquilla (40), Valle del Cauca (28), Meta (27), Caldas (22 ), Cartagena (15), Quindío (13), Cesar (11), Norte de Santander (9), Atlántico (9), Huila (7), Cauca (7), San Andrés (7), Boyacá (7) , Córdoba (7), La Guajira (5), Sucre (3), Santa Marta (3), Nariño (3), Casanare (3), Bolívar (3), Putumayo (2), Caquetá (1) and Guaviare (1 ).